RNU6-693P

Across TCGA pan-cancer cohorts, RNU6-693P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6-693P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-693P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-693P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KIRC, UCS, and PAAD are the cancer types where RNU6-693P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.208	0.662	.012	96	view →
UCS	OS	Tertile	All	0.135	0.687	.009	72	view →
PAAD	OS	Tertile	All	0.111	0.646	<.001	54	view →
LUSC	OS	Tertile	II,III,IV	0.054	0.780	<.001	54	view →
OV	OS	Tertile	IV	0.217	0.643	.003	36	view →
LGG	OS	Tertile	All	0.221	0.812	<.001	36	view →
HNSC	DFS	Tertile	III,IV	0.050	0.611	<.001	36	view →
ESCA	DFS	Tertile	II,III,IV	0.223	0.509	.013	27	view →
KIRP	DFS	Tertile	All	0.269	0.871	<.001	27	view →
THCA	DFS	Tertile	III,IV	0.149	0.741	.004	18	view →
CESC	DFS	Tertile	All	0.661	0.828	.024	12	view →
SARC	OS	Tertile	All	0.130	0.495	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU6-693P–KIRC (DFS)

Open the KIRC breakdown →